Truffle Capital Mergers and Acquisitions Summary

Private Equity Firm Profile

Truffle Capital’s most common sectors for investment arelife science (20%) and medical products (16%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (40%) and growth capital (29%). In total, Truffle Capital has invested in 3 US states and 8 different countries. Its largest (disclosed) acquisition occurred in 2007 when it acquired GoAdv for $8M.

The Firm’s most common exit type is ipo (50%). Truffle Capital’s largest (disclosed) exit occurred in 2015 when it sold Momac B.V. for $8M.

Join Mergr to view Truffle Capital’s full profile and discover more middle-market private equity firm investors just like it.

M&A Summary

  • M&A Total Activity62
    • M&A Buy Activity44
    • M&A Sell Activity18
  • Total Sectors Invested 19
  • Total Countries Invested 8
  • M&A Buy/Sell Connections 15
  • M&A Advisors 1

Truffle Capital

Truffle Capital

5, rue de la Baume,
Paris, 75008
France
+33 1 82 28 46 00
www.truffle.com
contact@truffle.com

Truffle Capital is a French private equity firm focused on majority investments in life science and information technology companies. Within IT, Truffle seeks businesses dealing in mobile content and connectivity, internet, technical software, IT security, and VOIP. Within the life science sector, the Firm looks at opportunities in therapeutic drugs and vaccines, medical devices, as well as other breakthrough technologies. Truffle Capital was formed in 2001 and is based in Paris.


Investment Criteria

Sectors of Interest: Environmental, Financial Services, Healthcare Services, Information Technology, Life Science, Medical Products, Software

Target Transaction Types: Buyout (LBO, MBO, MBI), Divestiture, Growth Capital, PIPE, Stake Purchase, Venture

Geographic Preferences: East US, Midwest US, South US, West US, United Kingdom, Western Europe

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.2/yr) # 43 1 - - - - 44
vol $11M $11M
Sell (0.0/yr) # 18 - - - - - 18
vol $8M $8M
  62

Most Recent M&A

Company Date Value Type
Caranx Medical 2020-01-01 - Buyout (LBO, MBO, MBI)
Paris, France · www.caranx-medical.com
SmartPush 2019-12-23 - Stake Purchase
Marseille, France · www.smartpush.io
BariaTek Medical SAS 2019-01-01 - Buyout (LBO, MBO, MBI)
Paris, France · www.bariatek-medical.com
PK MED 2019-01-01 - Buyout (LBO, MBO, MBI)
Paris, France · www.pk-med.com
DenyAll SAS 2016-12-20 - Trade Sale
Paris, France · www.denyall.com
Momac B.V. 2015-08-04 8M EUR Trade Sale
Rotterdam, Netherlands · www.momac.net
Abivax 2015-06-23 - IPO
, France · www.abivax.com
Immune Targeting Systems Ltd. 2015-02-17 - Trade Sale
London, United Kingdom
Altimmune, Inc. 2015-02-17 - Stake Purchase
Gaithersburg, Maryland · www.altimmune.com
Carbios SAS 2013-12-13 - IPO
Saint-Beauzire, France · www.carbios.fr
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 2 (40%) - 9 (20%) 3M (31%)
Medical Products 2 (40%) - 7 (16%) -
Software - - 5 (11%) -
Information Technology 1 (20%) - 4 (9%) -
Business Services - - 2 (4%) -
Energy Services and Equipment - - 2 (4%) -
Manufacturing - - 2 (4%) -
Renewable Energy - - 2 (4%) -
Technology Hardware - - 2 (4%) -
Media - - 1 (2%) 8M (69%)
Communications - - 1 (2%) -
Construction - - 1 (2%) -
Electronics - - 1 (2%) -
Healthcare Services - - 1 (2%) -
Internet Software and Services - - 1 (2%) -
Marketing - - 1 (2%) -
Metals/Mining - - 1 (2%) -
Oil/Gas Exploration - - 1 (2%) -
Semiconductors - - 1 (2%) -
Total 5 - 45 $11M

Acquisitions By Geo

State/Country Current # Value All-time # Value
France 4 (80%) - 33 (73%) 3M (31%)
United States 1 (20%) - 3 (7%) -
  Maryland 1 (20%) - 1 (2%) -
  Texas - - 1 (2%) -
  Massachusetts - - 1 (2%) -
Netherlands - - 3 (7%) -
Switzerland - - 2 (4%) -
Italy - - 1 (2%) 8M (69%)
United Kingdom - - 1 (2%) -
Austria - - 1 (2%) -
Luxembourg - - 1 (2%) -
Domestic 4 (80%) - 33 (73%) 3M (31%)
Cross-border 1 (20%) - 12 (27%) 8M (69%)
Total 5 - 45 $11M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 3 (60%) - 18 (40%) 11M (100%)
Growth Capital - - 13 (29%) -
Venture - - 8 (18%) -
Stake Purchase 2 (40%) - 4 (9%) -
Divestiture - - 2 (4%) -
Total 5 - 45 $11M

Exits by Deal Type

Type Total # Value
IPO 10 (56%) -
Trade Sale 6 (33%) -
Trade Sale - Public Company 2 (11%) 8M (100%)
Total 18 $8M

Top M&A Advisors

Financial Deals
McNamee Lawrence & Co. LLC
 1

Deal Values

buy # Total
< $100M 2 $11M
TOTAL $11M
Largest GoAdv
$8M (2007-09-17)
sell # Total
< $100M 1 $8M
TOTAL $8M
Largest Momac B.V.
$8M (2015-08-04)

M&A Connections

Deals
Acquired from
Investor(s)
2%
1 (2%)
Strategic(s)
4%
2 (4%)
Exited to
Investor(s)
6%
1 (6%)
Strategic(s)
44%
8 (44%)

Investor Summary

Investor Type

Private Equity Firm

Size

Middle-Market

PE Assets

700M EUR

Established

2001

Specialist/Generalist

Specialist

Leadership

Patrick Kron

Chairman

Bernard Louis Roques

Co-Founder & CEO

Philippe Pouletty

Co-Founder & CEO

Alain Chevallier

Senior Partner

Antoine Pau

Senior Partner

FAQ

When was Truffle Capital founded?

Truffle Capital was founded in 2001.

What type of investor is Truffle Capital?

Truffle Capital is a private equity firm.

Where is Truffle Capital headquartered?

Truffle Capital is headquartered in Paris, France.

How much capital does Truffle Capital have under management?

Truffle Capital has 700M EUR under management.

 Subscribe to unlock this and 201,353
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 193K M&A Transactions
  • 197K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal